G01N 2500/10
Involving cells
Official title: involving cells
G01N2500/10 (Involving cells) appears on 2,237 US grants and 4,474 published applications in this corpus.
Search patents in G01N- Granted patents
- 2,237
- Published applications
- 4,474
- Assignees
- 1,776
- Inventors
- 8,454
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 20 | 0 |
| 1998 | 25 | 0 |
| 1999 | 29 | 0 |
| 2000 | 26 | 0 |
| 2001 | 24 | 11 |
| 2002 | 40 | 101 |
| 2003 | 32 | 409 |
| 2004 | 30 | 174 |
| 2005 | 36 | 166 |
| 2006 | 73 | 142 |
| 2007 | 70 | 141 |
| 2008 | 62 | 111 |
| 2009 | 55 | 139 |
| 2010 | 94 | 195 |
| 2011 | 60 | 183 |
| 2012 | 66 | 153 |
| 2013 | 85 | 170 |
| 2014 | 116 | 181 |
| 2015 | 137 | 393 |
| 2016 | 132 | 275 |
| 2017 | 180 | 237 |
| 2018 | 164 | 188 |
| 2019 | 124 | 181 |
| 2020 | 123 | 175 |
| 2021 | 98 | 153 |
| 2022 | 83 | 126 |
| 2023 | 54 | 124 |
| 2024 | 67 | 131 |
| 2025 | 63 | 124 |
| 2026 | 45 | 91 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for transducing protein-protein interactions6 Oct 2026US 12,753,403 B2ETH Zurich
- Maintenance and/or culture of tissue slices in vitro or ex vivo15 Sep 2026US 12,736,523 B2National University of Singapore
- Method and system for detecting cell-killing efficacy and/or immune activity, and application thereof8 Sep 2026US 12,730,104 B2Shanghai Ruiyu Biotech Co., Ltd.
- Methods for modulation of coronavirus infection1 Sep 2026US 12,724,031 B2Laboratory Corporation of America Holdings
- Microfluidic-based device for in vivo wound infection model and uses thereof25 Aug 2026US 12,716,889 B2City Unversity of Hong Kong
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Methods and compositions for displaying peptide libraries8 Oct 2026US 2026/0308224 A1Board of Regents, The University of Texas System
- Compositions and methods for determining the effects of t cell engager8 Oct 2026US 2026/0309708 A1Arbele Limited
- Methods and tools for detecting the impact of compounds on protein, rna or dna interactions8 Oct 2026US 2026/0309718 A1Iktos
- Utility of protein in the prediction of in vivo effects1 Oct 2026US 2026/0298909 A1Qualyst Transporter Solutions, LLC
Most cited
By later US patents
- Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists245US 6,096,756 AAlbert Einstein College of Medicine of Yeshiva University · 2000
- Methods for the detection of soluble .beta.-amyloid peptide244US 5,593,846 AAthena Neurosciences, Inc. · 1997
- Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists234US 5,472,943 AAlbert Einstein College of Medicine of Yeshiva University · 1995
- High throughput processing system and method of using171US 7,390,458 B2Irm LLC · 2008
- Methods of screening for compounds which inhibit soluble .beta.-amyloid peptide production152US 5,766,846 AAthena Neurosciences, Inc. · 1998